The briefing argues that the chip sell-off reflects demand outrunning supply and a shortage of capital, not demand peaking. Lam Research said it cannot ship fast enough, while Meta's free cash flow turned negative and it created a new share class to fund AI. The abundance thesis still holds on the demand side. The near-term risk is funding: rates, oil and weaker balance sheets. At the same time, Unitree's rally in A-shares looks like crowding that deserves the same contrarian test.
Key signals
- The Philadelphia Semiconductor Index fell 6.72% on 10/22 to 10,731.98, its lowest close since 7/29. All 30 members fell.
- Lam's September-quarter revenue was $8.22B (+54%). Its December-quarter guide of $8.6B was held back by supply constraints, and it expects 2027 wafer-equipment spending above $200B.
- Meta posted revenue of $64.6B but free cash flow of -$2.12B. It created non-voting Class C shares, and its 5-year CDS hit a record 114.79bp.
- The 10-year Treasury is at 5.00% and Brent at $116.72.
- Unitree (688836:SSE) hit its 20% limit-up at 624, up 54% in seven sessions and 28% above the analyst average target of 485.86.
By theme
AI
Kimi K3.1 Pro ranked fourth on the Artificial Analysis index at 55, and open-weight models are narrowing the gap with closed models. The briefing's view: "the cheaper the models, the scarcer the compute," which favors NVDA, MU, TSM and ASML over pure model-API businesses. NVDA trades at 13.4x forward earnings and MU at 4.2x. Software (CRWD, NOW) rallied past consensus targets, which the briefing reads as a crowded safe haven.
Robotics
In the US, ISRG beat Q3 estimates and rose on target raises, while story-driven names (SYM, SERV) weakened. In A-shares, the briefing concludes: "buy components, sell assembler hype." Inovance trades at 22x forward earnings and Sanhua at 27x, against 224x for Unitree. Its reasoning is that general-purpose models becoming robot "brains" could turn robot assembly into a commodity.
Space
SpaceX reported Q3 revenue of $14.58B (+161%) and net income of $4.4B. It is also seeking 80,000 US base stations for its own wireless carrier. That raises valuation anchors for smaller space stocks but pulls liquidity away from them. ASTS was cut to Sell after Viasat's FCC objection and SpaceX's move into terrestrial wireless.
Biotech
In private markets, Pathos raised $237M at a $3B valuation and Warp Science raised $215M. BioXcel went bankrupt and was sold to Teva for $125M. The briefing's view is that value is moving from AI drug "platforms" to data plus automated wet labs. It favors revenue-generating data assets (TEM, NTRA, GH) and rates RXRX a Sell. LLY reports on 10/29 and REGN on 10/30.
Hong Kong, A-shares and crypto
The ChiNext index fell 3.21% at the open and closed up 4.16%, on turnover of RMB 1.96T. Physical AI stocks rose 10.50%, and optical-module makers said their order books were full. In Hong Kong, the Hang Seng fell 4.52% on the week. Tencent trades near its 52-week low at 11.3x forward earnings. AI tokens fell harder than AI stocks, with FET down 27.6% in a month. Singapore investors are warned to use only MAS-licensed platforms and avoid leverage.
Rating highlights
| Ticker | Company | Call | Why |
|---|---|---|---|
| LRCX:NASDAQ | Lam Research | Watch (downgraded) | Closed below stop at 239.95; wait for hyperscaler capex on 10/28–29 |
| CRDO:NASDAQ | Credo | Sell (downgraded) | Broke stop; AEC monopoly share publicly challenged; 1.6T cycle may slip |
| META:NASDAQ | Meta | Watch (downgraded) | Broke stop; negative FCF and Class C dilution |
| ISRG:NASDAQ | Intuitive Surgical | Hold (upgraded) | Q3 beat and three target raises; overbought, no adding |
| 300124:SZSE | Inovance | Hold (upgraded) | Core robot component leader at 22x forward PE; reclaimed cost basis |
| ASML:NASDAQ | ASML | Buy | Only equipment name with results already beaten; EUV irreplaceable; stop 1500 |
| NVDA:NASDAQ | Nvidia | Buy | 13.4x forward PE while demand accelerates; stop 205.18 |
| MU:NASDAQ | Micron | Buy | 4.2x forward PE; DRAM leads 2027 equipment spending |
| COHR:NYSE | Coherent | Buy | Cheapest optical name; 1.6T delay priced in; small position |
| 0700:HKEX | Tencent | Buy | 11.3x forward PE, profit +13%, near 52-week low; stop 378 |
| 300308:SZSE | Zhongji Innolight | Buy | 11.9x forward PE, profit tripled, order book full; stop 550 |
| 688836:SSE | Unitree | Sell | 121x sales, 28% above consensus target; rally driven by sentiment |
| ASTS:NASDAQ | AST SpaceMobile | Sell | SpaceX competition and Viasat FCC challenge; 134x sales |
| RXRX:NASDAQ | Recursion | Sell | Quarterly revenue -60%, short interest near 30% |
Tenbagger radar
- BKSY:NYSE (stayed): The evidence got stronger. Revenue grew 50.1% and the company won a seven-figure Gen-3 defense contract. The path multiple is about 6.3x. Next test: earnings on 11/5.
- 9880:HKEX (stayed, weaker): The rally cut the path multiple to 5.7x, and the net loss has not narrowed. It drops out if the stock rises another ~14%.
- LUNR:NASDAQ (entered): Revenue grew 309.8%, giving a path multiple of about 7.1x. A failed lunar landing removes it, and dilution risk is high.
- 2498:HKEX (entered): Cheapest robot-perception name at 3.0x sales, with about six years of cash runway. Growth is below the 30% threshold and must recover.
- 301510:SZSE (entered): A pure-play motion-control component supplier, with revenue up 66.9%. Its path is the thinnest of the five: 4.6x on a non-diluted basis, and it has no analyst coverage.
Risks to watch
- FOMC on 10/27–28, with the market watching for a December hike signal. The US midterms are on 11/3.
- MSFT and GOOGL report on 10/28 and AMZN on 10/29. If capex is raised and stocks still fall, the briefing would treat funding constraints as the main story.
- Lam's delayed shipments are expected to move into the March quarter. Whether that happens is still unverified.
- Brent above $116 and the 10-year at 5% put pressure on Neocloud companies, AI miners and AI tokens.